CONFORMATION SPECIFIC THERAPEUTIC VACCINES AGAINST PROTEIN MISFOLDING DISEASES

被引:0
|
作者
Nicolau, Claude [1 ]
机构
[1] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA
关键词
Alzheimer Disease; conformation-sensitive antibodies; liposomes; memory recovery; transgenic mice; BETA-AMYLOID FIBRILS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; IMMUNE-RESPONSE; P-GLYCOPROTEIN; MOUSE MODEL; PEPTIDE; IMMUNIZATION; CELLS; ACCUMULATION;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This is a brief review of our recent work concerning conformation-specific therapeutic vaccines, which have shown high efficacy against Alzheimer's Disease (AD), in animal models. The preparation of such vaccines, the determination of the antigen's conformation in the vaccine and the nature of the antibodies ellicited are discussed. The mechanism of the antibody action, in vitro and in vivo has been elucidated. The anti-amyloid vaccine is presently in a Phase I Clinical Trial on AD patients.
引用
收藏
页码:317 / +
页数:8
相关论文
共 50 条
  • [31] Nanomedicine and protein misfolding diseases
    Kransnoslobodtsev, Alexey V.
    Shlyakhtenko, Luda S.
    Ukraintsev, Egor
    Zaikova, Tatiana O.
    Keana, John F. W.
    Lyubchenko, Yuri L.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2005, 1 (04) : 300 - 305
  • [32] Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases
    Cheng, Biao
    Gong, Hao
    Xiao, Hongwen
    Petersen, Robert B.
    Zheng, Ling
    Huang, Kun
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (10): : 4860 - 4871
  • [33] Protein misfolding and degradation in genetic diseases
    Bross, P
    Corydon, TJ
    Andresen, BS
    Jorgensen, MM
    Bolund, L
    Gregersen, N
    HUMAN MUTATION, 1999, 14 (03) : 186 - 198
  • [34] Nanoimaging for protein misfolding and related diseases
    Lyubchenko, Yuri L.
    Sherman, Simon
    Shlyakhtenko, Luda S.
    Uversky, Vladimir N.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (01) : 53 - 70
  • [35] Developing therapeutics for the diseases of protein misfolding
    May, BCH
    Govaerts, C
    Cohen, FE
    NEUROLOGY, 2006, 66 : S118 - S122
  • [36] Protein Misfolding and Neurodegenerative Diseases Introduction
    Diamond, Marc I.
    NEUROTHERAPEUTICS, 2013, 10 (03) : 369 - 370
  • [37] Chaperones and Cardiac Misfolding Protein Diseases
    Christians, Elisabeth S.
    Mustafi, Soumyajit B.
    Benjamin, Ivor J.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2014, 15 (03) : 189 - 204
  • [38] Protein-misfolding diseases and the paradigm of proteomics-based therapeutic targets Foreword
    Singh, Om V.
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (04) : 463 - 464
  • [39] Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose
    Sirangelo, Ivana
    Irace, Gaetano
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (12) : 1311 - 1321
  • [40] Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases
    Hekmatimoghaddam, Seyedhossein
    Zare-Khormizi, Mohamad Reza
    Pourrajab, Fatemeh
    BIOFACTORS, 2017, 43 (06) : 737 - 759